drugset / Trial / NCT00006168

Ursodiol-Methotrexate for Primary Biliary Cirrhosis

NCT00006168 ↗

RandomizedDouble-blindTreatment

Summary

The major thrust is to determine whether treatment of patients with Primary Biliary Cirrhosis (PBC) with Ursodiol (Ursodeoxycholic Acid-UDCA) plus methotrexate (MTX) is more effective than treatment with UDCA alone.

Timeline

Start
1994-01
Primary completion
—
Completion
2004-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule — —

Indications